Free Trial
OTCMKTS:XSNX

NovAccess Global (XSNX) Stock Price, News & Analysis

NovAccess Global logo

About NovAccess Global Stock (OTCMKTS:XSNX)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
19 shs
Market Capitalization
$10 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NovAccess Global Inc. is a biotechnology company focused on developing treatments for glioblastoma, an aggressive form of brain cancer. The company’s work centers on novel therapeutic approaches intended to address the significant challenges associated with treating tumors in the central nervous system.

NovAccess Global has described its product-development efforts as focused on targeted cancer therapies and drug-delivery technologies designed to improve treatment access to brain tumors. The company remains in the development stage, and publicly available information about its commercial products, operating footprint and clinical programs is limited.

The company previously operated under the name XsunX Inc. and trades under the symbol XSNX. Detailed, independently verifiable information regarding its current leadership team and geographic operations was not readily available.

AI Generated. May Contain Errors.

Receive XSNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XSNX Stock News Headlines

NovAccess Global
Global wage calculator: Compare your salary
Elon Musk… A Total Fraud?
Jeff Brown, the former tech executive who picked Nvidia in 2016 before it surged as high as 37,800 percent, just got inside Elon Musk's new Cybercab, a vehicle with no steering wheel or pedals. In 2018, the New York Post called Musk a total fraud. Brown's latest footage shows just how far that technology has come since then.tc pixel
NovAccess Global Inc.
NovAccess Global Inc. (XSNX)
See More Headlines

XSNX Stock Analysis - Frequently Asked Questions

NovAccess Global Inc. (OTCMKTS:XSNX) posted its quarterly earnings results on Wednesday, January, 14th. The company reported ($0.06) EPS for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that NovAccess Global investors own include GE Aerospace (GE), Medical Marijuana (MJNA), Beazer Homes USA (BZH), Grayscale Bitcoin Trust ETF (GBTC), Aurora Cannabis (ACBFF), Agritek (AGTK) and American Cannabis (AMMJ).

Company Calendar

Last Earnings
1/14/2026
Today
11/01/2026
Fiscal Year End
9/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:XSNX
CIK
1039466
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
61,650,000
Free Float
60,764,000
Market Cap
$10 thousand
Optionable
Not Optionable
Beta
2.18
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (OTCMKTS:XSNX) was last updated on 10/30/2026 by MarketBeat.com Staff.
From Our Partners